Keys To Handling Digital Investigations In Pharma IP Litigation

Across global pharmaceutical markets, disputes over patents, intellectual property and go-to-market strategies have persisted for decades between large pharmaceutical companies and generics manufacturers. These disputes are often expensive and time-intensive, and may hinder the process of bringing generics to market.

Read more